findmyKOL
Clinical trialNCT04245397RecruitingPhase 1Interventional

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

SponsorSyntrix Biosystems, Inc.Enrollment151Myelodysplastic Syndromes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic

    Jacksonville, Florida, United States

    Hemant S Murthy, MD
    Recruiting
  • University of Miami

    Miami, Florida, United States

    Namrata S Chandhok, MD
    Recruiting
  • Adventhealth Medical Group & Bone Marrow Transplant at Orlando

    Orlando, Florida, United States

    Arlene Gayle, M.D.
    Recruiting
  • Moffitt Cancer Center

    Tampa, Florida, United States

    David A Sallman, MD
    Recruiting
  • Emory University

    Atlanta, Georgia, United States

    Anthony M Hunter, MD
    Recruiting
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, Maryland, United States

    Amy E DeZern, MD, MHS
    Recruiting
  • Montefiore Medical Center

    The Bronx, New York, United States

    Mendel Goldfinger, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2020
Primary completion
31 Mar 2028
Completion
31 Mar 2029
Last update posted
23 Dec 2025
Registered enrollment
151
Registry id
NCT04245397
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.